APA (7th ed.) Citation

Battelli, N., Mocerino, C., Montedoro, M., Pistelli, M., Portarena, I., Rosanova, M., . . . Vici, P. New Therapeutic Scenarios in the Context of Adjuvant Treatment for HR+/HER2−Breast Cancer: The Possible Role of Ribociclib in Treatment Algorithms for Stage II and III. MDPI AG.

Chicago Style (17th ed.) Citation

Battelli, Nicola, Carmela Mocerino, Michele Montedoro, Mirco Pistelli, Ilaria Portarena, Mario Rosanova, Tina Sidoni, and Patrizia Vici. New Therapeutic Scenarios in the Context of Adjuvant Treatment for HR+/HER2−Breast Cancer: The Possible Role of Ribociclib in Treatment Algorithms for Stage II and III. MDPI AG.

MLA (9th ed.) Citation

Battelli, Nicola, et al. New Therapeutic Scenarios in the Context of Adjuvant Treatment for HR+/HER2−Breast Cancer: The Possible Role of Ribociclib in Treatment Algorithms for Stage II and III. MDPI AG.